Penile prosthesis coating and the reduction of postoperative infection

Current Urology Reports

Volumn 5, Issue 6, 2004, Pages 460-466

  Abouassaly, Robert ^b   Montague, Drogo K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

Antimicrob Agent; Central Venous Catheter; Erectile Dysfunction; Minocycline; Rifampin

Indexed keywords

ANTIINFECTIVE AGENT; BIOMATERIAL;

ANTIBIOTIC PROPHYLAXIS; HUMAN; INFECTION; MALE; MALE GENITAL SYSTEM SURGERY; PENIS PROSTHESIS; REVIEW;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; COATED MATERIALS, BIOCOMPATIBLE; HUMANS; MALE; PENILE IMPLANTATION; PENILE PROSTHESIS; PROSTHESIS-RELATED INFECTIONS;

EID: 16644399477     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-004-0071-1     Document Type: Article

References (63)

1. Carson CC: Management of prosthesis infections in urologic surgery. Urol Clinics North Am 1999, 26:829–839. Review dealing with every aspect of penile prosthesis infection. DOI: 10.1016/S0094-0143(05)70223-8
2. Montague DK, Angermeier KW, Lakin MM: Penile prosthesis infections. Int J Imp Res 2001, 13:326–328. DOI: 10.1038/sj.ijir.3900768
3. Jarow JP: Risk factors for penile prosthetic infection. J Urol 1996, 156:402–404. This study attempts to elucidate the risk factors for infection in penile prostheses. DOI: 10.1016/S0022-5347(01)65860-9
4. Carson CC: Diagnosis, treatment, and prevention of penile prosthesis infection. Int J Imp Res 2003, 15:S139-S146. Recent review summarizing relevant studies in penile prosthesis infection. DOI: 10.1038/sj.ijir.3901091
5. Wilson SK, Delk JR: Inflatable penile implant infection: predisposing factors and treatment suggestions. J Urol 1995, 153:659–661. Large study looking at risk factors for infection in penile prostheses. DOI: 10.1016/S0022-5347(01)67678-X
6. Roberts JA, Fussell EN, Lewis RW: Bacterial adherence to penile prosthesis. Int J Impot Res 1989, 1:167–178.
7. Carson CC, Robertson CN: Late hematogenous infection to penile prosthesis. J Urol 1988, 139:112–118.
8. Fishman IJ, Scott FB, Selam IN: Rescue procedure: an alternative to complete removal for treatment of infected penile prosthesis. J Urol 1987, 137:202A.
9. Carson CC: Infections in genitourinary prostheses. Urol Clin North Am 1989, 16:139–147.
10. Licht MR, Montague DK, Angermeier KW, et al.: Cultures from genitourinary prostheses at reoperation: questioning the role of staphylococcus epidermidis in periprosthetic infection. J Urol 1995, 154:387–390. One of the first studies highlighting the prevalence of bacterial colonization of penile prostheses. DOI: 10.1016/S0022-5347(01)67058-7
11. Henry GD, Wilson SK, Delk JR, et al.: Inflatable penile prosthesis culture during revision surgery. Abstract Presented at the American Urological Association Annual Meeting. Chicago: April 26–May 3, 2003.
12. Radomski SB, Herschorn S: Risk factors associated with penile prosthesis infection. J Urol 1992, 147:383–385.
13. Garber BB, Marcus SM: Does surgical approach affect the incidence of inflatable penile prosthesis infection? Urology 1998, 52:291–293. DOI: 10.1016/S0090-4295(98)00186-1
14. Fallon B, Ghanem H: Infected penile prosthesis: incidence and outcomes. Int J Impot Res 1989, 1:175–188.
15. Bishop JR, Moul JW, Sihelnik SA, et al.: Use of glycosylated hemoglobin to identify diabetics at high risk for penile prosthetic infections. J Urol 1992, 147:386–388.
16. Wilson SK, Carson CC, Cleves MA, et al.: Quantifying risks of penile prosthesis infection with elevated glycosylated hemoglobin. J Urol 1998, 159:1537–1540. DOI: 10.1097/00005392-199805000-00034
17. Brant MD, Ludlow JK, Mulcahy JJ: The prosthesis salvage operation: immediate replacement of the infected penile prosthesis. J Urol 1996, 155:155–157. DOI: 10.1016/S0022-5347(01)66580-7
18. Mulcahy JJ: Long-term experience with salvage of infected penile implants. J Urol 2000, 163:481–482. DOI: 10.1016/S0022-5347(05)67906-2
19. Costerton JW, Cheng KJ, Geesey GG, et al.: Bacterial biofilms in nature and disease. Ann Rev Microbiol 1987, 41:435–464. DOI: 10.1146/annurev.mi.41.100187.002251
20. Silverstein A, Donatucci CF: Bacterial biofilms and implantable prosthetic devices. Int J Impot Res 2003, S5:S150–154. Excellent review dealing with bacterial biofilms on prosthetic devices, with an emphasis on the penile prosthesis. DOI: 10.1038/sj.ijir.3901093
21. Costerton JW: Introduction to biofilm. Int J Antimicrobial Agents 1999, 11:217–221. DOI: 10.1016/S0924-8579(99)00018-7
22. Silverstein AD, Evans B, Pasmore M: Biofilm formation on clinically non-infected penile prosthetic surfaces. Abstract Presented at the American Urological Association Annual Meeting. San Francisco: May 8–13, 2004.
23. Evans RC, Holmes CJ: Effect of vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomers. Antimicrob Agents Chemother 1987, 31:889–894.
24. Choong S, Whitfield H: Biofilms and their role in infections in urology. BJU Int 2000, 86:935–941. Review focusing on biofilms in urology. DOI: 10.1046/j.1464-410x.2000.00949.x
25. De Torres WR, Carson CC: Antibiotic prophylaxis in urologic surgery. Curr Opin Urol 1995, 5:48–54. DOI: 10.1097/00042307-199501000-00012
26. Maffezzini M, Capone M, Ciampalini S: Antibiotic prophylaxis in prosthetic penile surgery: critical assessment of results in 75 consecutive patients. Int J Impot Res 1996, 8:87–89.
27. Kabalin JN, Kessler R: Infectious complications of penile prosthesis surgery. J Urol 1988, 139:953–955.
28. Randrup ER: Clinical experience with 180 inflatable penile prostheses. South Med J 1995, 88:47–51.
29. Classen DC, Evans RS, Pestotnik SL, et al.: Timing of prophylactic administration of antibiotics and the risk of surgical wound infection. N Engl J Med 1992, 326:281–286. This is a landmark paper on the timing of antibiotic prophylaxis in surgery. This study provides strong evidence for administering antibiotics prior to skin incision. DOI: 10.1056/NEJM199201303260501
30. Acar O, Mutlu B, Cimen K, et al.: The role of intraoperative antibiotic irrigation and postoperative antibiotic therapy for contaminated implantable prosthesis: in a rat model in vivo. Int J Impot Res 2000, 12:285–288. DOI: 10.1038/sj.ijir.3900604
31. Towers AG, Stinson NE: The effect of an antimicrobial coating on metal implants: a pilot study in goats. Acta Orthopaedica Scandinavica 1996, 37:211–218.
32. Schierholz JM, Steinhauser H, Rump AFE, et al.: Controlled release of antibiotics from biomedical polyurethanes: morphological and structural features. Biomaterials 1997, 18:839–844. DOI: 10.1016/S0142-9612(96)00199-8
33. Raad I, Darouiche R: Central venous catheters (CVC) coated with minocycline and rifampin (M/R) for the prevention of catheter-related bacteremia (CRB) [Abstract J7]. In Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology; 1995:258.
34. Raad I, Darouiche R, Hachem R, et al.: Antibiotics and prevention of microbial colonization of catheters. Antimicrob Agents Chemother 1995, 39:2397–2400.
35. Raad I, Dariouche R, Dupuis J, et al.: Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections: a randomized, double-blind trial. Ann Intern Med 1997, 127:267–274.
36. Darouiche RO, Hampel OZ, Boone TB: Antimicrobial activity and durability of a novel antimicrobial-impregnated bladder catheter. Int J Antimicrob Agents 1997, 8:243–247. DOI: 10.1016/S0924-8579(97)00015-0
37. Darouiche RO, Smith JA Jr, Hanna H, et al.: Efficacy of antimicrobial-impregnated bladder catheters in reducing catheter-associated bacteriuria: a prospective, randomized, multicenter clinical trial. Urology 1999, 54:976–981. DOI: 10.1016/S0090-4295(99)00288-5
38. Li H, Fairfax MR, Dubocq F, et al.: Antibacterial activity of antibiotic coated silicone grafts. J Urol 1998, 160:1910–1913. This is an important early study that provided the foundation for antibiotic coatings on penile prostheses. The study indicates that this antibiotic coating may decrease the device colonization rate. DOI: 10.1016/S0022-5347(01)62442-X
39. InhibiZone, antibiotic surface treatment. In Preclinical study. Data on file, Minnetonka, MN: American Medical Systems, Inc.; 2001.
40. Sherertz RJ, Carruth WA, Hampton AA, et al.: Efficacy of antibiotic coated catheters in preventing subcutaneous Staphylococcus aureus infection in rabbits. J Infect Dis 1993, 167:98–106.
41. Brock G, Bochinski D: InhibiZone treatment: the first antibiotic treatment impregnated into the tissue-contacting surface of an inflatable penile prosthesis. Abstract Presented at the American Urological Association Annual Meeting. Anaheim. CA: June 2–7, 2001.
42. Brock G, Bochinski D: InhibiZone treatment: the first antibiotic treatment impregnated into the tissue-contacting surface of an inflatable penile prosthesis. Abstract Presented at the American Urological Association Annual Meeting. Anaheim. CA: June 2–7, 2001.
43. Ryan RT, Jones LA: Early experience with antibiotic impregnated inflatable penile prosthesis (IPP) in a high-risk patient population. Abstract Presented at the South Central Section American Urological Association Meeting. Colorado Springs, CO: October 5–9, 2002.
44. Wilson SK, Henry GD, Del JR, et al.: Prevention of infection in revision of penile prostheses by using antibiotic coated prosthesis and Mulcahy salvage protocol. Abstract Presented at the American Urological Association Annual Meeting. Chicago: April 26–May 1, 2003.
45. Abouassaly R, Angermeier KW, Montague DK: Risk of infection with use of an antibiotic-coated penile prosthesis at the time of device replacement for mechanical failure. Abstract Presented at the American Urological Association Annual Meeting. San Francisco: May 8–13, 2004.
46. Carson CC: Efficacy of antibiotic impregnation of inflatable penile prostheses in decreasing infection in original implants. J Urol 2004, 171:1611–1614. This study provides the strongest evidence that applying an antibiotic coating to penile prostheses may decrease the subsequent infection rate. DOI: 10.1097/01.ju.0000118245.66976.e1
47. Jansen B, Jansen S, Peters G, et al.: In vitro efficacy of a central venous catheter (‘hydrocath’) loaded with teicoplanin to prevent bacterial colonization. J Hosp Infect 1992, 22:93–107. This study supplies evidence that a hydrophilic coating on the penile prosthesis may decrease device infection rate. DOI: 10.1016/0195-6701(92)90093-2
48. Boelens JJ, Tan WF, Dankert J, et al.: Antibacterial activity of antibiotic-soaked polyvinlypyrrolidone-grafted silicone elastomer hydrocephalus shunts. J Antimicrob Chemother 2000, 45:221–224. DOI: 10.1093/jac/45.2.221
49. Hellstrom WJ, Hyun JS, Human L, et al.: Antimicrobial activity of antibiotic-soaked, Resist-coated Bioflex. Int J Impot Res 2003, 15:18–21. DOI: 10.1038/sj.ijir.3900941
50. Wolter C, Rajpurkar AD, Kendirci M, et al.: Hydrophilic-coated inflatable penile prosthesis: 1-year experience. Abstract Presented at the American Urological Association Annual Meeting. San Francisco: May 8–13, 2004. This study provides early evidence that penile prostheses with a hydrophilic coating may contribute to decreased device infection rates.
51. Karchmer AW, Archer GL, Dismukes WE: Rifampin treatment of prosthetic valve endocarditis due to Staphylococcus epidermidis. Rev Infect Dis 1983, 5(suppl 3):S543-S548.
52. Wheat LJ, Kohler RB, Luft FC, et al.: Long-term studies of the effect of rifampin on nasal carriage of coagulase-positive staphylococci. Rev Infect Dis 1983, 5(suppl 3):S459-S462.
53. Minuth JN, Holmes TM, Musher DM, et al.: Activity of tetracycline, doxycycline, and minocycline against methicillin-susceptible and -resistant staphylococci. Antimicrob Agents Chemother 1974, 6:411–414.
54. Testa RT, Petersen, PJ, Jacobus NV, et al.: In vitro and in vivo antibacterial activities of the glycylcyclines: a new class of semisynthetic tetracyclines. Antimicrob Agents Chemother 1993, 37:2270–2277.
55. Robertson JM, Reeve EC: Analysis of the resistance mediated by several R-factors to tetracycline and minocycline. Genet Res 1972, 20:239–252. DOI: 10.1017/S0016672300013744
56. Speer BS, Shoemaker NB, Saylers AA: Bacterial resistance to tetracycline: mechanisms, transfer, and clinical significance. Clin Microbiol Rev 1992, 5:387–399.
57. Nishijima S, Akamatsu H, Akamatsu M, et al.: The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne. J Dermatol 1994, 21:166–171.
58. Segretti J, Gvazdinskas LC, Trenholme GM: In vitro activity of minocycline and rifampin against staphylococci. Diagn Microbiol Infect Dis 1989, 12:253–255. DOI: 10.1016/0732-8893(89)90022-9
59. Yourassowsky E, Vander Linden MP, Lismont JJ, et al.: Combination of minocycline and rifampin against methicillin-and gentamycin-resistant Staphylococcus aureus. J Clin Path 1981, 34:559–563. DOI: 10.1136/jcp.34.5.559
60. Clumeck N, Marcelis L, Amiri-Lamraski MH, et al.: Treatment of severe staphylococcal infections with a rifampicin-minocycline association. J Antimicrob Chemother 1984, 13:17–22.
61. Darouiche R, Wright C, Hamill R, et al.: Eradication of colonization by methicillin-resistant Staphylococcus aureus by using oral minocyline-rifampin and topical mupirocin. Antimicrob Agents Chemother 1991, 35:1612–1615.
62. Darouiche RO, Raad II, Bodey GP, et al.: Antibiotic susceptibility of staphylococcal isolates from patients with vascular catheter-related bacteremia: potential role of the combination of minocycline and rifampin. Int J Antimicrob Agents 1995, 6:31–36. DOI: 10.1016/0924-8579(95)00017-3
63. Tambe SM, Sampath L, Modak SM: In vitro evaluation of the risk of developing bacterial resistance to antiseptics and antibiotics used in medical devices. J Antimicrob Chemother 2001, 47:589–598. DOI: 10.1093/jac/47.5.589